Andrés is a bioinformatician working at the intersection of AI and genomics, with expertise in cancer and bacterial genomics. Over the course of two decades, he has conducted extensive research at leading institutions, including the National Cancer Institute (NCI/NIH) and prestigious Universities in his home country. Since 2022, Andrés has pioneered AI-Augmented Development for bioinformatics: – Integrating GenAI into bioinformatics pipelines. - Deweponizing the mind-code interfase. – And building resilient, scalable software for biological research.